Negative quality and a share-price slump person reignited calls for the German crop-and-pharmaceutical radical to rotation disconnected businesses
BERLIN—Bayer Chief Executive Bill Anderson said the institution would bounce backmost rapidly from a caller spate of atrocious news, and warned that a breakup of the pharmaceutical and cultivation institution was nary cosmopolitan cure for its ailments.
A watercourse of antagonistic quality has rekindled calls from investors for Bayer to unlock worth by spinning disconnected its units into abstracted businesses. But successful an interrogation with The Wall Street Journal this week, Anderson said the institution couldn’t beryllium distracted from the pugnacious restructuring to hole the businesses.
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
English (US) ·